Advanced therapies

Cell and gene therapy

Personalized medicine requires a personal touch.

Rapidly deliver life-changing therapies to your patients, backed by comprehensive support

At Cencora, we are committed to transforming the landscape of advanced therapies with tailored services throughout the product life cycle. With a proven track record of successfully bringing complex products to market globally, we leverage extensive regulatory expertise, strategic consulting, and innovative logistics solutions to help you navigate the intricate pathways of product development.

Why partner with Cencora?

From early discovery through commercialization, our holistic approach integrates critical functional areas to help emerging biopharma companies and established players alike to accelerate their journey to deliver life-changing therapies to patients worldwide.
7+
years of CGT partnership
230+
active cell and gene biopharma partners
12,000+
global cryogenic shipments annually

Our solutions that support advanced therapies

Regulatory affairs and CMC

Navigating global health authorities is complex, especially with an advanced therapy. Cencora is a partner with a proven history of bringing transformative therapies to market. We offer guidance informed by regular engagements with global agencies, chemistry manufacturing controls (CMC) services, and assistance with special designations and programs for advanced therapies, helping you navigate the evolving regulatory landscape.

Market access strategy

Supporting access to innovative therapies for patients is anything but straightforward. We can help you differentiate and deliver your brand's value proposition worldwide, offering timely advice on market access strategy and execution throughout the product life cycle.

Patient safety (pharmacovigilance)

Promoting patient safety is a top priority, especially when your patients are ill and have few treatment options. Our pharmacovigilance services support manufacturers in recording the safety and efficacy of therapies from clinical development through post-market surveillance with a team experienced in U.S., European, and Canadian regulations and reporting standards.

Third-party logistics (3PL)

Cencora offers innovative logistics solutions tailored to the unique needs of advanced therapies. Our quality-centered approach encompasses transport, warehousing, inventory management, and distribution, ensuring that products are delivered efficiently and securely to support clinical and commercial operations.

Specialty distribution networks

Advanced therapies involve complex handling requirements and patient journeys. Our experts can assist in designing a channel strategy that evolves as your product matures. We offer solutions for order-to-cash management to help provide optimal market and patient access. Our global distribution centers feature temperature-controlled solutions, ensuring patients receive the products they need precisely when they need them.

Specialty logistics

Gain reliable, efficient, and safe supply chain management for high-value products through Cencora’s network of over 100 3PL facilities and transport stations. With over 50 years of experience in global shipments, we excel in managing the logistics of life-saving therapies. We provide temperature-controlled solutions and a partnership-driven approach, allowing clients to focus on breakthroughs while we handle logistical complexities.

Patient access services

Guiding a patient through a complicated treatment journey from point of enrollment through treatment administration is challenging. We have created a unified experience for providers and manufacturers through a single, easy-to-use solution that gives all stakeholders visibility into the eligibility process. This makes it easier than ever to request support either on demand or timed across key milestones of the treatment journey.
 

Connecting manufacturers and providers to the services needed for full end-to-end patient and order management

The Cencora Orchestration Exchange for cell and gene therapies provides a connected experience, offering manufacturers and providers visibility across the entire treatment journey. Cencora's extensive capabilities in distribution, order-to-cash, storage, global courier services, and patient services can be seamlessly integrated with manufacturer-preferred platforms. This turnkey, configurable solution supports rapid launch.
Available in English only

Cell and gene therapy resources

Article

Tips for partnering with health systems: A critical step for CGT commercialization

Sotrovimab

Article

How cell and gene therapy developers can reduce risk of FDA complete response letters with proactive CMC strategies

Article

CMC struggles in CGTs: Why manufacturing and quality are critical to meeting FDA expectations

Cell and gene therapy press releases

Media statement September 24, 2025

Cencora to Support Commercial Launch of Precigen’s Novel Immunotherapy in the United States

Executive perspective April 28, 2025

Cencora to Support Commercial Launch of Neurotech’s Encapsulated Cell Therapy in the United States
 

Connect with our cell and gene experts

At Cencora, we are at the forefront of advancing cell and gene therapies, offering comprehensive, integrated support that spans the entire product lifecycle. With a legacy of successfully bringing complex and transformative therapies to market globally, we combine deep regulatory expertise, strategic consulting, and specialized logistics to help our clients navigate the intricacies of development and commercialization. 

Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.